Carolina Blood and Cancer Care Associates PA-Lancaster — Lancaster, South Carolina

Carolina Blood and Cancer Care Associates PA-Lancaster is a clinical research site located in Lancaster, South Carolina, United States 29720.

Crixeo Health Trust Score: 79/100 (FAIR). This profile has not yet been claimed by the site owner.

Carolina Blood and Cancer Care Associates PA-Lancaster has participated in 26 clinical trials with 7 currently active.

Therapeutic areas: Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative, Adenocarcinoma of the Prostate.

Sponsors: National Cancer Institute (NCI), Alliance for Clinical Trials in Oncology, SWOG Cancer Research Network.

Sponsor Feasibility Report

Trust Score: 79/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Carolina Blood and Cancer Care Associates PA-Lancaster?

Carolina Blood and Cancer Care Associates PA-Lancaster has a Crixeo Trust Score of 79/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Carolina Blood and Cancer Care Associates PA-Lancaster conducted?

Carolina Blood and Cancer Care Associates PA-Lancaster has 26 clinical trials on record, with 7 currently active. Their work covers Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative, Adenocarcinoma of the Prostate.

Is Carolina Blood and Cancer Care Associates PA-Lancaster accredited by Crixeo Health?

Carolina Blood and Cancer Care Associates PA-Lancaster has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Carolina Blood and Cancer Care Associates PA-Lancaster?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.